Outcomes and Impact of Age on Therapy for Multiple Myeloma Outcomes and Impact of Age on Therapy for Multiple Myeloma
Is lenalidomide with low-dose dexamethasone effective for stem-cell transplantation-ineligible patients of any age with newly diagnosed MM?Journal of Clinical Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
More News: Cancer & Oncology | Dexamethasone | Health | Hematology | Myeloma | Revlimid | Stem Cell Therapy | Stem Cells | Transplants